Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![GSK plc Graphic](https://lunarcrush.com/gi/w:26/t:gsk-plc.png) GSK plc (GSK)

GSK's key blood cancer drug faces likely rejection in the U.S., triggering concerns across the biotech space. However, GSK is also shipping influenza vaccine doses for the 2025-26 flu season.

### About GSK plc
GSK plc (GSK) is a pharmaceutical company.  
GSK plc uses the ticker $GSK for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/gsk-plc/insights)
- GSK plc (GSK) trading volume is up XX% from the previous week.
- GSK plc (GSK) social dominance is up XXXXX% from the previous week.
- GSK plc (GSK) engagements is up XXXXXX% from the previous week.
- GSK plc (GSK) mentions is up XXXXXX% from the previous month.
- GSK plc (GSK) posts created is up XXXXXX% from the previous month.

### Price: $XXXXX [#](/topic/gsk-plc/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/gsk-plc/time-series/close.tsv)  
The price is trending upward, likely driven by recent positive news about acquisitions and drug approvals, with the latest news indicating GSK begins shipping influenza vaccine doses for the 2025-26 flu season.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | -XXXX% |

**1-Year High**: $XXXXX on 2024-09-04  
**1-Year Low**: $XXXXX on 2025-01-14  
  
  
### AltRank: XXX [#](/topic/gsk-plc/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/gsk-plc/time-series/alt_rank.tsv)  
GSK plc (GSK) is currently AltRank #895 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +775  
**1 Month**: XXX -XXX  
**6 Months**: XXX +352  
**1 Year**: XXX +5  
**1-Year High**: XXXXX on 2024-11-11  
**1-Year Low**: X on 2025-02-09  
  
  
### Galaxy Score: XXXXX [#](/topic/gsk-plc/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/gsk-plc/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -X  
**1 Month**: XX +8  
**6 Months**: XX -X  
**1 Year**: XX -XX  
**1-Year High**: XX on 2025-05-13  
**1-Year Low**: XX on 2025-07-03  
  
  
### Engagements: XXXXXX [#](/topic/gsk-plc/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/gsk-plc/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXXX +142%  
**1 Month**: XXXXXXX +23%  
**6 Months**: XXXXXXXXX -XX%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2024-12-05  
**1-Year Low**: XXX on 2025-04-20  

| Social Network | X      | YouTube | Reddit | News |
| -------------- | -      | ------- | ------ | ---- |
| Engagements    | XXXXXX | X       | X      | X    |
  

  
  
### Mentions: XXX [#](/topic/gsk-plc/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/gsk-plc/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX +44%  
**1 Month**: XXXXX +152%  
**6 Months**: XXXXX +13%  
**1 Year**: XXXXX +97%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2024-09-29  

| Social Network | X   | YouTube | Reddit | News |
| -------------- | -   | ------- | ------ | ---- |
| Mentions       | XXX | X       | X      | X    |
  

  
  
### Creators: XXX [#](/topic/gsk-plc/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/gsk-plc/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning GSK plc (GSK) in the last XX hours which is down XX% from XXX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +223%  
**6 Months**: XXXXX +35%  
**1 Year**: XXXXX +145%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2024-09-29  

The most influential creators that mention GSK plc in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | XX    | XXXXX       |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXXXX       |
| [@Stone_Trades1](/creator/twitter/Stone_Trades1)     | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/gsk-plc/100)
  
  
### Sentiment: XX% [#](/topic/gsk-plc/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/gsk-plc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% -X%  
**6 Months**: XX% -XX%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-09-02  
**1-Year Low**: XX% on 2025-01-26  

**Most Supportive Themes**
- **New Drug Approvals and Acquisition:** (55%) Positive data, new drug approvals, and the acquisition of a new drug are driving positive sentiment around GSK.
- **Positive outlook on new drugs:** (25%) Positive outlook on new drugs and the potential for these drugs to have a large impact on sales growth.
  
**Most Critical Themes**
- **Drug Price & GLP-1 Drug Concerns:** (0.5%)  Concerns about drug prices and risks associated with GLP-1 drugs are being discussed.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXXXX    | XX% |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
| Reddit  | X        | X%  | X       | X%  | X        | X%  |
| News    | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXXXX    | XX% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/gsk-plc/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/gsk-plc/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.016%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% +0.0074%  
**1 Year**: XXXXX% +0.0031%  
**1-Year High**: XXXXX% on 2025-06-28  
**1-Year Low**: XXXXX% on 2025-07-09  
  
  
### Market Dominance: XXXXX% [#](/topic/gsk-plc/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/gsk-plc/time-series/market_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2024-09-07  
**1-Year Low**: XXXXX% on 2025-07-19  
  
  
### Market Cap: $XXXXXXXXXXXXXX [#](/topic/gsk-plc/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:gsk-plc/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/gsk-plc/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXX -$0.56%  
**1 Month**: $XXXXXXXXXXXXXX -$1.50%  
**6 Months**: $XXXXXXXXXXXXXX +$13%  
**1 Year**: $XXXXXXXXXXXXXX -$4%  
**1-Year High**: $XXXXXXXXXXXXXX on 2024-09-04  
**1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-14  

**Top assets mentioned**
In the posts about GSK plc in the last XX hours

[Hims & Hers Health, Inc. (HIMS)](/topic/$hims)
[GSK plc (GSK)](/topic/$gsk)
[Omnicom Group Inc. (OMC)](/topic/$omc)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Synthetify (SNY)](/topic/$sny)
[Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Molina Healthcare, Inc. (MOH)](/topic/$moh)
[Novartis AG (NVS)](/topic/$nvs)

**Top topics mentioned**
In the posts about GSK plc in the last XX hours

[manat](/topic/manat), [$hims](/topic/$hims), [hims](/topic/hims), [$vani](/topic/$vani), [pfe](/topic/pfe), [stocks healthcare](/topic/stocks-healthcare), [$zldpf](/topic/$zldpf), [asml](/topic/asml), [jnj](/topic/jnj), [mstr](/topic/mstr), [stocks](/topic/stocks), [qqq](/topic/qqq), [$ive](/topic/$ive), [wm](/topic/wm), [vix](/topic/vix), [$omc](/topic/$omc), [$lly](/topic/$lly), [$sny](/topic/$sny), [abbv](/topic/abbv), [$rhhby](/topic/$rhhby), [$regn](/topic/$regn), [$jnj](/topic/$jnj), [jacob](/topic/jacob), [$moh](/topic/$moh), [$vgsh](/topic/$vgsh), [nvda](/topic/nvda), [op](/topic/op), [$jd](/topic/$jd), [$nvs](/topic/$nvs), [moh](/topic/moh), [investment](/topic/investment), [bdx](/topic/bdx), [amzn](/topic/amzn), [spy](/topic/spy), [sbux](/topic/sbux), [spx](/topic/spx), [hood](/topic/hood), [dow](/topic/dow), [$iei](/topic/$iei), [pltr](/topic/pltr), [coins healthcare](/topic/coins-healthcare), [nke](/topic/nke), [rog](/topic/rog), [mmm](/topic/mmm), [dd](/topic/dd), [stockmarket](/topic/stockmarket), [$etsy](/topic/$etsy), [$asnd](/topic/$asnd), [$repl](/topic/$repl), [$djt](/topic/$djt), [$vtrs](/topic/$vtrs), [$gild](/topic/$gild), [cfg](/topic/cfg), [$scha](/topic/$scha), [$vrtx](/topic/$vrtx), [$kalv](/topic/$kalv), [tak](/topic/tak), [gibraltar pound](/topic/gibraltar-pound), [$brcc](/topic/$brcc), [ibkr](/topic/ibkr), [teva](/topic/teva), [hum](/topic/hum), [vale](/topic/vale), [srm](/topic/srm), [soc](/topic/soc), [$vymi](/topic/$vymi), [icu](/topic/icu), [luv](/topic/luv), [$mmm](/topic/$mmm), [$crm](/topic/$crm), [meta](/topic/meta), [$se](/topic/$se), [$rblx](/topic/$rblx), [telo](/topic/telo), [canadian](/topic/canadian), [approved](/topic/approved), [$alv](/topic/$alv), [drugs](/topic/drugs), [jpm](/topic/jpm), [$azn](/topic/$azn), [$cogt](/topic/$cogt), [$meta](/topic/$meta), [$legn](/topic/$legn), [crcl](/topic/crcl), [acquisition](/topic/acquisition), [$20s](/topic/$20s), [$cvac](/topic/$cvac), [told](/topic/told), [$deck](/topic/$deck), [$bti](/topic/$bti), [sonn](/topic/sonn), [elf](/topic/elf), [rio](/topic/rio), [$luv](/topic/$luv), [$xbi](/topic/$xbi), [$ibb](/topic/$ibb), [china](/topic/china), [$hlncf](/topic/$hlncf), [$vrnas](/topic/$vrnas), [positions](/topic/positions)

### Top Social Posts [#](/topic/gsk-plc/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$ES $SPY $SPX $QQQ $TQQQ $TSLA $AAPL $KO $F $META $NVDA $NQ $MSFT $GOOG $AMZN $AI $BTC $NKE $JNJ $PYPL $DIS $SBUX $VIX $WM $NVO $TSM $ASML $GSK $MSFT $MSTR"  
[@Stone_Trades1](/creator/x/Stone_Trades1) on [X](/post/tweet/1946596895264243902) 2025-07-19 15:44:00 UTC 7362 followers, XXX engagements


"🦉 For weight loss CagriSema ranked highest with XXXXX kg followed by tirzepatide and retatrutide. Adverse events rose with dose notably GI issues making tolerability a key factor. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  
[@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592287380632026) 2025-07-19 15:25:41 UTC 4960 followers, XXX engagements


"🦉 Tirzepatide led glycaemic control with a XXXX% HbA1c drop and XXXX mmol/L fasting glucose outperforming XX other GLP-1RAs. Its dose-efficacy was linear peaking at XX mg weekly. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  
[@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592284067192895) 2025-07-19 15:25:41 UTC 4960 followers, XXX engagements


"💼Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type X diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"  
[@AponiaAnalytics](/creator/x/AponiaAnalytics) on [X](/post/tweet/1946592280942375206) 2025-07-19 15:25:40 UTC 4960 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

GSK plc Graphic GSK plc (GSK)

GSK's key blood cancer drug faces likely rejection in the U.S., triggering concerns across the biotech space. However, GSK is also shipping influenza vaccine doses for the 2025-26 flu season.

About GSK plc

GSK plc (GSK) is a pharmaceutical company.
GSK plc uses the ticker $GSK for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

  • GSK plc (GSK) trading volume is up XX% from the previous week.
  • GSK plc (GSK) social dominance is up XXXXX% from the previous week.
  • GSK plc (GSK) engagements is up XXXXXX% from the previous week.
  • GSK plc (GSK) mentions is up XXXXXX% from the previous month.
  • GSK plc (GSK) posts created is up XXXXXX% from the previous month.

Price: $XXXXX #

Price Line Chart
Price 24-Hour Chart Data
The price is trending upward, likely driven by recent positive news about acquisitions and drug approvals, with the latest news indicating GSK begins shipping influenza vaccine doses for the 2025-26 flu season.

24-Hour 7-Day 30-Day
-XXXX% -XXXX% -XXXX%

1-Year High: $XXXXX on 2024-09-04
1-Year Low: $XXXXX on 2025-01-14

AltRank: XXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
GSK plc (GSK) is currently AltRank #895 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX +775
1 Month: XXX -XXX
6 Months: XXX +352
1 Year: XXX +5
1-Year High: XXXXX on 2024-11-11
1-Year Low: X on 2025-02-09

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX +8
6 Months: XX -X
1 Year: XX -XX
1-Year High: XX on 2025-05-13
1-Year Low: XX on 2025-07-03

Engagements: XXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +142%
1 Month: XXXXXXX +23%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2024-12-05
1-Year Low: XXX on 2025-04-20

Social Network X YouTube Reddit News
Engagements XXXXXX X X X

Mentions: XXX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXX +44%
1 Month: XXXXX +152%
6 Months: XXXXX +13%
1 Year: XXXXX +97%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2024-09-29

Social Network X YouTube Reddit News
Mentions XXX X X X

Creators: XXX #

Creators Line Chart
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning GSK plc (GSK) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XX
1 Week: XXX -XX%
1 Month: XXX +223%
6 Months: XXXXX +35%
1 Year: XXXXX +145%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2024-09-29

The most influential creators that mention GSK plc in the last XX hours

Creator Rank Followers Posts Engagements
@AponiaAnalytics X XXXXX XX XXXXX
@BiopharmIQ X XXXXXX X XXXXX
@Stone_Trades1 X XXXXX X XXX

View More

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% -X%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-09-02
1-Year Low: XX% on 2025-01-26

Most Supportive Themes

  • New Drug Approvals and Acquisition: (55%) Positive data, new drug approvals, and the acquisition of a new drug are driving positive sentiment around GSK.
  • Positive outlook on new drugs: (25%) Positive outlook on new drugs and the potential for these drugs to have a large impact on sales growth.

Most Critical Themes

  • Drug Price & GLP-1 Drug Concerns: (0.5%) Concerns about drug prices and risks associated with GLP-1 drugs are being discussed.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXX XX% XXXXX XX% XXXXX XX%
YouTube X X% X X% X X%
Reddit X X% X X% X X%
News X X% X X% X X%
Total XXXXX XX% XXXXX XX% XXXXX XX%

Social Dominance: XXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.016%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% +0.0074%
1 Year: XXXXX% +0.0031%
1-Year High: XXXXX% on 2025-06-28
1-Year Low: XXXXX% on 2025-07-09

Market Dominance: XXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXX% on 2024-09-07
1-Year Low: XXXXX% on 2025-07-19

Market Cap: $XXXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX -$0.56%
1 Month: $XXXXXXXXXXXXXX -$1.50%
6 Months: $XXXXXXXXXXXXXX +$13%
1 Year: $XXXXXXXXXXXXXX -$4%
1-Year High: $XXXXXXXXXXXXXX on 2024-09-04
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-14

Top assets mentioned In the posts about GSK plc in the last XX hours

Hims & Hers Health, Inc. (HIMS) GSK plc (GSK) Omnicom Group Inc. (OMC) Eli Lilly and Company (LLY) Synthetify (SNY) Regeneron Pharmaceuticals Inc (REGN) Johnson & Johnson (JNJ) Molina Healthcare, Inc. (MOH) Novartis AG (NVS)

Top topics mentioned In the posts about GSK plc in the last XX hours

manat, $hims, hims, $vani, pfe, stocks healthcare, $zldpf, asml, jnj, mstr, stocks, qqq, $ive, wm, vix, $omc, $lly, $sny, abbv, $rhhby, $regn, $jnj, jacob, $moh, $vgsh, nvda, op, $jd, $nvs, moh, investment, bdx, amzn, spy, sbux, spx, hood, dow, $iei, pltr, coins healthcare, nke, rog, mmm, dd, stockmarket, $etsy, $asnd, $repl, $djt, $vtrs, $gild, cfg, $scha, $vrtx, $kalv, tak, gibraltar pound, $brcc, ibkr, teva, hum, vale, srm, soc, $vymi, icu, luv, $mmm, $crm, meta, $se, $rblx, telo, canadian, approved, $alv, drugs, jpm, $azn, $cogt, $meta, $legn, crcl, acquisition, $20s, $cvac, told, $deck, $bti, sonn, elf, rio, $luv, $xbi, $ibb, china, $hlncf, $vrnas, positions

Top Social Posts #

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$ES $SPY $SPX $QQQ $TQQQ $TSLA $AAPL $KO $F $META $NVDA $NQ $MSFT $GOOG $AMZN $AI $BTC $NKE $JNJ $PYPL $DIS $SBUX $VIX $WM $NVO $TSM $ASML $GSK $MSFT $MSTR"
@Stone_Trades1 on X 2025-07-19 15:44:00 UTC 7362 followers, XXX engagements

"🦉 For weight loss CagriSema ranked highest with XXXXX kg followed by tirzepatide and retatrutide. Adverse events rose with dose notably GI issues making tolerability a key factor. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4960 followers, XXX engagements

"🦉 Tirzepatide led glycaemic control with a XXXX% HbA1c drop and XXXX mmol/L fasting glucose outperforming XX other GLP-1RAs. Its dose-efficacy was linear peaking at XX mg weekly. $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:41 UTC 4960 followers, XXX engagements

"💼Comparative effectiveness of GLP-1 receptor agonists on glycaemic control body weight and lipid profile for type X diabetes $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS #glp1 #diabetes"
@AponiaAnalytics on X 2025-07-19 15:25:40 UTC 4960 followers, XXX engagements

GSK plc (GSK)
/topic/$gsk